A menstrual history was taken from the female partners of all new infertility couples seen in our clinic between 1988 and 1990. The body mass index (Kg/M 2 ) was measured in all females. The ovulatory status was studied using a combination of serial transvaginal ultrasound investigations and progesterone measurements in the second half of the cycle in females with regular menstrual cycles or progesterone measurements one week before the expected onset of menstruation in females with oligomenorrhea. Amenorrheic patients were considered anovulatory if no anatomical abnormality was found. Out of the 1755 patients, only 17% were in the normal weight category (BMI 19-24), 42% were overweight (BMI25-29) and 38% were obese (BMI 30 or more), while the remaining 3% were underweight. With increasing BMI, the percentage of oligomenorrhea increased from 18% to 32%, the percentage of amenorrhea increased from 2% to 13%. The overall percentage of anovulation increased from 32% to 55%. Ann Saudi Med 1995;15(4): CJCM Hamilton, KA Jaroudi, UV Sieck, High Prevalence of Obesity in a Saudi Infertility Population. 1995; 15(4): 344-346Obesity has important health implications. Among others, there is an increased risk to develop diabetes mellitus, hypertension and cardiovascular disease.
The report consists of summary in vitro fertilization (IVF) results for the period of 1986 to 1992, concerning 2426 IVF cycles on 954 patients. Tubal factor accounted for 48.7% of cases; male factor, 15.2%; unexplained factors, 15.8%; tubal plus male factor, 12.2%; with 7.7% miscellaneous pathologies. Stimulation regimes were of seven varieties over the period described. All cycles were monitored by transvaginal ultrasound and serum estradiol/LH. All oocyte retrievals were carried out at 34 hours post-HCG. Standard laboratory procedures were utilized for oocyte and pre-embryo culture and a maximum of four embryos were replaced approximately 48 hours after ovum pickup (OPU). Luteal support was by either progesterone suppository or intramuscular injection for 14 days following embryo transfer. Average number of oocytes per retrieval was 7.8, with a fertilization rate of 54% over all groups. Two hundred and sixty-eight pregnancies were initiated (16.1% per embryo transfer [ET]) with 53 of these being biochemical. Pregnancy rates followed a learning curve in the early years with a plateau at 17.8% per ET. Thus, the IVF program has evolved to yield acceptable results after refinement of stimulation regimes, laboratory techniques (especially with regard to sperm preparation), ET techniques and luteal support, thereby tailoring its protocols to suit the local population.
The correlation between sperm motion characteristics and in vitro fertilization was studied in 160 cycles, divided in two groups: those with male subfertility (N=42) and those with tubal disease (N=118). The group with male subfertility showed inferior performance, as indicated by a lower fertilization rate per oocyte (40% versus 66%) and per pick-up cycle (67% versus 93%). These two groups exhibited no significant difference in the mean sperm velocity, linearity, amplitude of lateral head displacement, and beat cross frequency in the pre swim-up and post swim-up specimens. The two groups differed in pre and post swim-up sperm motility, pre and post swim-up concentration, pre swim-up cumulative velocity at 110 to 140 µm/sec and post swim-up cumulative velocity at 130 µm/sec. Logistic regression analysis was used to determine those variables that would predict fertilization; pre swim-up count and post swim-up motility proved to be the significant determinants. The results indicate that assessment of motion by automated semen analyzers does not supplement conventional semen analysis in the ability to predict fertilization. Ann Saudi Med 1994;14 (5) In vitro fertilization (IVF) and embryo transfer (ET) are the currently accepted methods for compensating for the effects of male subfertility.1 However, the pregnancy rate remains lower than that achieved in case of tubal disease. This is secondary to the lower fertilization rate seen in this group.2 Preceding the institution of IVF-ET in couples with male subfertility, predictors of fertilization are customarily used to assess the suitability of IVF-ET as a treatment. An array of fertilization predictors are currently in use, ranging from traditional semen analysis to diagnostic IVF. 1,3 Computerized semen analysis was introduced into clinical practice in the hopes of improving speed, consistency, and objectivity in evaluating concentration and motility, plus providing new parameters generated by motion analysis. Unfortunately, concentration and percentage motility as reported by automated semen analyzer are unreliable when compared to conventional semen analysis. Sperm concentration is usually underestimated, while motility is usually overestimated by computerized semen analysis. For this reason, 4,5 it is recommended not to replace the conventional procedure by automated semen analyzers.Besides concentration and percentage motility, computerized semen analysis generates several other sperm motion characteristics like velocity, linearity, amplitude of lateral head displacement and beat cross frequency. These parameters do not have their equivalent in the conventional semen analysis.The aim of this study was to evaluate whether these sperm motion characteristics have any predictive value for in vitro fertilization. Material and MethodsSelection Criteria -All IVF cycles dealt with during January 1989 to January 1990, and for which we were able to retrieve motion analysis data, were reviewed. Forty-two cycles had male factor infertility and 118 cycles had pure tubal fac...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.